person · Reporting owner

ROBBINS LARRY

Disclosed activity across 6 companies

Tapewire entity: 14629
SEC CIK: 0001228603

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Brookdale Senior Living Inc.BKD · Entity 4268	10% owner	September 25, 2019	September 27, 2019
Butterfly Network, Inc.BFLY · Entity 4467	Director	August 13, 2026	August 17, 2026
CVS HEALTH CorpCVS · Entity 2884	Director	May 19, 2026	May 21, 2026
Longview Acquisition Corp. IILGV · Entity 122524	Director · 10% owner	March 18, 2021	March 23, 2021
MERITOR, INC.MTOR · Entity 124864	10% owner	October 08, 2019	October 18, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Brookdale Senior Living Inc.

Report date September 25, 2019 · Filed September 27, 2019

Jointly reported with GLENVIEW CAPITAL MANAGEMENT, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	17,633,572	Reported balance Holding disclosure · report date 2019-09-25 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 17,633,572 F1: These shares of the Issuer's Common Stock (the "Shares") and call options ("Options") are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F2: Each Reporting Person disclaims beneficial ownership of the Shares and Options except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.
Call Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2022-02-11	IndirectSee Footnotes	Not disclosed	Reported balance Holding disclosure · report date 2019-09-25 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance Not disclosed F3: The Reporting Persons do not have the right to exercise the Options within 60 days, do not have direct or indirect voting power or investment power over the Shares underlying the Options, and do not have the right to acquire such power over such Shares within 60 days. Further, the Reporting Persons do not believe they have acquired the Shares or Options with the purpose or effect of changing or influencing the control of the Issuer or in connection with or as a participant in any transaction having such purpose or effect. F4: Notwithstanding, based on Rule 13d-3(d) under the Exchange Act, the Reporting Persons began including the Shares underlying the Options in their beneficial ownership calculation as of the date of their Schedule 13D, and accordingly are filing this Form 3. Excluding the Options, the Reporting Persons are not over-10% beneficial owners, and are not otherwise subject to section 16 the Exchange Act, with respect to the Shares, and the filing of this Form 3 should not be construed as an admissions that the Reporting Persons are, for purposes of section 13 or section 16 of the Act, the beneficial owners of any Shares underlying the Options. F1: These shares of the Issuer's Common Stock (the "Shares") and call options ("Options") are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F2: Each Reporting Person disclaims beneficial ownership of the Shares and Options except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: These shares of the Issuer's Common Stock (the "Shares") and call options ("Options") are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.

F2: Each Reporting Person disclaims beneficial ownership of the Shares and Options except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.

F3: The Reporting Persons do not have the right to exercise the Options within 60 days, do not have direct or indirect voting power or investment power over the Shares underlying the Options, and do not have the right to acquire such power over such Shares within 60 days. Further, the Reporting Persons do not believe they have acquired the Shares or Options with the purpose or effect of changing or influencing the control of the Issuer or in connection with or as a participant in any transaction having such purpose or effect.

F4: Notwithstanding, based on Rule 13d-3(d) under the Exchange Act, the Reporting Persons began including the Shares underlying the Options in their beneficial ownership calculation as of the date of their Schedule 13D, and accordingly are filing this Form 3. Excluding the Options, the Reporting Persons are not over-10% beneficial owners, and are not otherwise subject to section 16 the Exchange Act, with respect to the Shares, and the filing of this Form 3 should not be construed as an admissions that the Reporting Persons are, for purposes of section 13 or section 16 of the Act, the beneficial owners of any Shares underlying the Options.

Butterfly Network, Inc.

Report date August 13, 2026 · Filed August 17, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	12,243,530	Reported balance After 2026-08-13 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-08-13 · Sale · Disposed 215,233 · Balance 12,243,530 F1: These shares of the Issuer's common stock, par value $0.0001 per share (the "Shares"), were sold by Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. F2: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $9.43 to $9.575, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3: Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F5: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	11,743,530	Reported balance After 2026-08-13 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2026-08-13 · Sale · Disposed 500,000 · Balance 11,743,530 F6: These Shares were sold by Glenview Offshore Opportunity Master Fund, Ltd. F7: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $9.035 to $9.3408, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3: Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F5: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	4,371,387	Reported balance After 2026-08-13 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-08-13 · Sale · Disposed 175,300 · Balance 4,371,387 F8: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $8.86 to $9.12, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F4: Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. F5: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	3,546,687	Reported balance After 2026-08-14 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2026-08-14 · Sale · Disposed 824,700 · Balance 3,546,687 F9: This price reflects the weighted average price for open-market sales of Shares on August 14, 2026 within a $1.00 range. The actual prices for these transactions range from $8.36 to $8.94, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F4: Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. F5: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	2,964,187	Reported balance After 2026-08-17 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 5 · 2026-08-17 · Sale · Disposed 582,500 · Balance 2,964,187 F10: This price reflects the weighted average price for open-market sales of Shares on August 17, 2026 within a $1.00 range. The actual prices for these transactions range from $8.85 to $9.07, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F4: Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. F5: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
Class A Common StockSEC Table I · non-derivative	Direct	390,952	Reported balance Holding disclosure · report date 2026-08-13 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 390,952

Filing footnotes · ownership attribution and instrument terms

F1: These shares of the Issuer's common stock, par value $0.0001 per share (the "Shares"), were sold by Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P.

F2: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $9.43 to $9.575, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3: Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

F4: Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities.

F5: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F6: These Shares were sold by Glenview Offshore Opportunity Master Fund, Ltd.

F7: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $9.035 to $9.3408, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F8: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $8.86 to $9.12, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F9: This price reflects the weighted average price for open-market sales of Shares on August 14, 2026 within a $1.00 range. The actual prices for these transactions range from $8.36 to $8.94, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F10: This price reflects the weighted average price for open-market sales of Shares on August 17, 2026 within a $1.00 range. The actual prices for these transactions range from $8.85 to $9.07, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

CVS HEALTH Corp

Report date May 19, 2026 · Filed May 21, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectHeld by Glenview Investment Funds	4,824,799	Last balance in matching sequence After 2026-05-21 transaction · row 7 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 7 source rows Row 1 · 2026-05-19 · Sale · Disposed 1,983,387 · Balance 6,213,412 F1: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F2: This price reflects the weighted average price for open-market sales of Shares on May 19, 2026 within a $1.00 range. The actual prices for these transactions range from $94.18 to $95.175, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Row 2 · 2026-05-19 · Sale · Disposed 151 · Balance 6,213,261 F1: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Row 3 · 2026-05-20 · Sale · Disposed 797,628 · Balance 5,415,633 F1: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F5: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $93.25 to $94.19, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Row 4 · 2026-05-20 · Sale · Disposed 152,691 · Balance 5,262,942 F1: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F6: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $94.25 to $95.245, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Row 5 · 2026-05-20 · Sale · Disposed 66,881 · Balance 5,196,061 F1: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F7: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $95.25 to $96.21, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Row 6 · 2026-05-20 · Sale · Disposed 800 · Balance 5,195,261 F1: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F8: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $96.25 to $96.34, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Row 7 · 2026-05-21 · Sale · Disposed 370,462 · Balance 4,824,799 F1: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F9: This price reflects the weighted average price for open-market sales of Shares on May 21, 2026 within a $1.00 range. The actual prices for these transactions range from $93.125 to $93.83, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.
Cash-Settled SwapsSEC Table II · derivative / convertible security · Conversion / exercise price $58.29 · Expires 2027-09-16	IndirectHeld by Glenview Investment Funds	0	Reported balance After 2026-05-21 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2026-05-21 · Sale · Disposed 378,000 · Balance 0 F10: These cash-settled swaps reference shares of the Issuer's common stock (the "Swaps") and are held for the account of the GO Fund. F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F11: The GO Fund is the record holder of the Swaps. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to the GO Fund. The Reporting Person shares voting and dispositive power over the Swaps held by the GO Fund and may be deemed to beneficially own such Swaps.

Filing footnotes · ownership attribution and instrument terms

F1: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

F2: This price reflects the weighted average price for open-market sales of Shares on May 19, 2026 within a $1.00 range. The actual prices for these transactions range from $94.18 to $95.175, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

F4: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

F5: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $93.25 to $94.19, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F6: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $94.25 to $95.245, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F7: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $95.25 to $96.21, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F8: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $96.25 to $96.34, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F9: This price reflects the weighted average price for open-market sales of Shares on May 21, 2026 within a $1.00 range. The actual prices for these transactions range from $93.125 to $93.83, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F10: These cash-settled swaps reference shares of the Issuer's common stock (the "Swaps") and are held for the account of the GO Fund.

F11: The GO Fund is the record holder of the Swaps. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to the GO Fund. The Reporting Person shares voting and dispositive power over the Swaps held by the GO Fund and may be deemed to beneficially own such Swaps.

Longview Acquisition Corp. II

Report date March 18, 2021 · Filed March 23, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	5,500,000	Reported balance After 2021-03-18 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2021-03-18 · Purchase · Acquired 5,500,000 · Balance 5,500,000 F1: Represents part of units of the Issuer purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one share of Class A common stock of the Issuer and one-fifth of one warrant ("Warrant") with each whole Warrant entitling the holder to purchase one share of Class A common stock at $11.50 per share. The Warrants will become exercisable 30 days after the completion of the Issuer's initial business combination. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Person. F2: 5,000,000 units are held for the accounts of Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P. and Glenview Offshore Opportunity Master Fund, Ltd. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and Glenview Offshore Opportunity Master Fund, Ltd. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. 500,000 units are held directly by an investment entity affiliated with the Reporting Person. F3: The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents part of units of the Issuer purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one share of Class A common stock of the Issuer and one-fifth of one warrant ("Warrant") with each whole Warrant entitling the holder to purchase one share of Class A common stock at $11.50 per share. The Warrants will become exercisable 30 days after the completion of the Issuer's initial business combination. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Person.

F2: 5,000,000 units are held for the accounts of Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P. and Glenview Offshore Opportunity Master Fund, Ltd. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and Glenview Offshore Opportunity Master Fund, Ltd. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. 500,000 units are held directly by an investment entity affiliated with the Reporting Person.

F3: The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

MERITOR, INC.

Report date October 08, 2019 · Filed October 18, 2019

Jointly reported with GLENVIEW CAPITAL MANAGEMENT, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	7,207,435	Reported balance Holding disclosure · report date 2019-10-08 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 7,207,435 F1: These shares of the Issuer's Common Stock (the "Shares") and call options ("Options") are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F2: Each Reporting Person disclaims beneficial ownership of the Shares and Options except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.
Call Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2020-02-05	IndirectSee Footnotes	Not disclosed	Reported balance Holding disclosure · report date 2019-10-08 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance Not disclosed F3: The Reporting Persons do not have the right to exercise the Options within 60 days, do not have direct or indirect voting power or investment power over the Shares underlying the Options, and do not have the right to acquire such power over such Shares within 60 days. Further, the Reporting Persons do not believe they have acquired the Options with the purpose or effect of changing or influencing the control of the Issuer or in connection with or as a participant in any transaction having such purpose or effect. F4: Notwithstanding Footnote 3, based on Rule 13d-3(d) under the Exchange Act, the Reporting Persons began including the Shares underlying the Options in their beneficial ownership calculation as of the date of their Schedule 13D, and accordingly are filing this Form 3. Excluding the Options, the Reporting Persons are not over-10% beneficial owners, and are not otherwise subject to Section 16 the Exchange Act, with respect to the Shares, and the filing of this Form 3 should not be construed as an admission that the Reporting Persons are, for purposes of Section 13 or Section 16 of the Exchange Act, the beneficial owners of any Shares underlying the Options. F1: These shares of the Issuer's Common Stock (the "Shares") and call options ("Options") are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F2: Each Reporting Person disclaims beneficial ownership of the Shares and Options except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F2: Each Reporting Person disclaims beneficial ownership of the Shares and Options except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.

F3: The Reporting Persons do not have the right to exercise the Options within 60 days, do not have direct or indirect voting power or investment power over the Shares underlying the Options, and do not have the right to acquire such power over such Shares within 60 days. Further, the Reporting Persons do not believe they have acquired the Options with the purpose or effect of changing or influencing the control of the Issuer or in connection with or as a participant in any transaction having such purpose or effect.

F4: Notwithstanding Footnote 3, based on Rule 13d-3(d) under the Exchange Act, the Reporting Persons began including the Shares underlying the Options in their beneficial ownership calculation as of the date of their Schedule 13D, and accordingly are filing this Form 3. Excluding the Options, the Reporting Persons are not over-10% beneficial owners, and are not otherwise subject to Section 16 the Exchange Act, with respect to the Shares, and the filing of this Form 3 should not be construed as an admission that the Reporting Persons are, for purposes of Section 13 or Section 16 of the Exchange Act, the beneficial owners of any Shares underlying the Options.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

TENET HEALTHCARE CORP

Report date April 21, 2021 · Filed April 22, 2021

Jointly reported with GLENVIEW CAPITAL MANAGEMENT, LLC

Section 16 reporting ended · disclosed 2021-04-22. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $0.05 par valueSEC Table I · non-derivative	IndirectSee footnotes	10,645,320	Last balance in matching sequence After 2021-04-22 transaction · row 5 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 5 source rows Row 1 · 2021-04-21 · Sale · Disposed 64,090 · Balance 13,608,836 F1: These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. F2: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 21, 2021 within a $1.00 range. The actual prices for these transactions range between $50.5554.305 to $51.342555.2929, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F8: These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F9: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 2 · 2021-04-21 · Sale · Disposed 58,000 · Balance 13,550,836 F1: These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. F3: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 21, 2021 within a $1.00 range. The actual prices for these transactions range between $55.535 to $55.60, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F8: These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F9: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 3 · 2021-04-22 · Sale · Disposed 2,572,941 · Balance 10,977,895 F1: These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. F8: These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F9: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 4 · 2021-04-22 · Sale · Disposed 249,702 · Balance 10,728,193 F1: These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. F4: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $56.045 to $57.04, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F8: These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F9: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 5 · 2021-04-22 · Sale · Disposed 82,873 · Balance 10,645,320 F1: These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. F5: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $57.045 to $57.665, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F8: These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. F9: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Common Stock, $0.05 par valueSEC Table I · non-derivative	Direct	0	Last balance in matching sequence After 2021-04-22 transaction · row 7 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 6 · 2021-04-22 · Sale · Disposed 26,197 · Balance 26,197 F6: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $54.87 to $54.99, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F9: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 7 · 2021-04-22 · Sale · Disposed 26,197 · Balance 0 F7: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $56.22 to $56.42, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F9: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC.

F2: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 21, 2021 within a $1.00 range. The actual prices for these transactions range between $50.5554.305 to $51.342555.2929, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F3: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 21, 2021 within a $1.00 range. The actual prices for these transactions range between $55.535 to $55.60, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F4: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $56.045 to $57.04, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F5: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $57.045 to $57.665, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F6: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $54.87 to $54.99, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F7: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $56.22 to $56.42, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

F8: These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.

F9: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 17, 2026 Filed Aug 17, 2026 23:01 UTC	Butterfly Network, Inc. BFLY · Entity 4467	SaleClass A Common Stock	582,500	$8.97	$5,225,141.50	Disclosure SEC source: 0000905148-26-003784 · form4.xml · nonDerivative · entry 5 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,964,187 F10 · price: This price reflects the weighted average price for open-market sales of Shares on August 17, 2026 within a $1.00 range. The actual prices for these transactions range from $8.85 to $9.07, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F4 · ownership.nature: Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
August 14, 2026 Filed Aug 17, 2026 23:01 UTC	Butterfly Network, Inc. BFLY · Entity 4467	SaleClass A Common Stock	824,700	$8.70	$7,172,663.31	Disclosure SEC source: 0000905148-26-003784 · form4.xml · nonDerivative · entry 4 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,546,687 F9 · price: This price reflects the weighted average price for open-market sales of Shares on August 14, 2026 within a $1.00 range. The actual prices for these transactions range from $8.36 to $8.94, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F4 · ownership.nature: Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
August 13, 2026 Filed Aug 17, 2026 23:01 UTC	Butterfly Network, Inc. BFLY · Entity 4467	SaleClass A Common Stock	175,300	$8.86	$1,553,228.12	Disclosure SEC source: 0000905148-26-003784 · form4.xml · nonDerivative · entry 3 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,371,387 F8 · price: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $8.86 to $9.12, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F4 · ownership.nature: Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
August 13, 2026 Filed Aug 17, 2026 23:01 UTC	Butterfly Network, Inc. BFLY · Entity 4467	SaleClass A Common Stock	500,000	$9.24	$4,617,750.00	Disclosure SEC source: 0000905148-26-003784 · form4.xml · nonDerivative · entry 2 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 11,743,530 F6 · shares: These Shares were sold by Glenview Offshore Opportunity Master Fund, Ltd. F7 · price: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $9.035 to $9.3408, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
August 13, 2026 Filed Aug 17, 2026 23:01 UTC	Butterfly Network, Inc. BFLY · Entity 4467	SaleClass A Common Stock	215,233	$9.54	$2,053,710.24	Disclosure SEC source: 0000905148-26-003784 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 12,243,530 F1 · shares: These shares of the Issuer's common stock, par value $0.0001 per share (the "Shares"), were sold by Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. F2 · price: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $9.43 to $9.575, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
August 03, 2026 Filed Aug 3, 2026 22:11 UTC	Butterfly Network, Inc. BFLY · Entity 4467	SaleClass A Common Stock	156,163	$8.10	$1,265,669.88	Disclosure SEC source: 0000905148-26-003455 · form4.xml · nonDerivative · entry 2 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 12,458,763 F1 · shares: These shares of the Issuer's common stock, par value $0.0001 per share (the "Shares"), were transferred by Glenview Capital Master Fund, Ltd. to GCM Onshore Investors, L.P. and GCM Cayman Investors, Ltd. on July 1, 2026, in a transaction exempt from Section 16 of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16a-13 thereunder, and were subsequently sold by GCM Onshore Investors, L.P. and GCM Cayman Investors, Ltd. F3 · ownership.nature: GCM Onshore Investors, L.P., GCM Cayman Investors, Ltd., Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment advisor or investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
July 31, 2026 Filed Aug 3, 2026 22:11 UTC	Butterfly Network, Inc. BFLY · Entity 4467	SaleClass A Common Stock	1,720,129	$7.39	$12,716,053.63	Disclosure SEC source: 0000905148-26-003455 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 12,614,926 F1 · shares: These shares of the Issuer's common stock, par value $0.0001 per share (the "Shares"), were transferred by Glenview Capital Master Fund, Ltd. to GCM Onshore Investors, L.P. and GCM Cayman Investors, Ltd. on July 1, 2026, in a transaction exempt from Section 16 of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16a-13 thereunder, and were subsequently sold by GCM Onshore Investors, L.P. and GCM Cayman Investors, Ltd. F2 · price: This price reflects the weighted average price for open-market sales of Shares on July 31, 2026 within a $1.00 range. The actual prices for these transactions range from $7.2282 to $7.82, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: GCM Onshore Investors, L.P., GCM Cayman Investors, Ltd., Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment advisor or investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
June 22, 2026 Filed Jun 22, 2026 23:06 UTC	Butterfly Network, Inc. BFLY · Entity 4467	GrantClass A Common Stock	25,447	$0.00	$0.00	Disclosure SEC source: 0002064832-26-000236 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,952 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2027 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date. Read SEC document
May 21, 2026 Filed May 21, 2026 21:43 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCash-Settled Swaps · Derivative	378,000	$93.31 Strike: $58.29	$35,271,558.00	Disclosure SEC source: 0000905148-26-002617 · form4.xml · derivative · entry 8 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 0 Underlying: Common Stock · 378,000 shares Expires 2027-09-16 F10 · security: These cash-settled swaps reference shares of the Issuer's common stock (the "Swaps") and are held for the account of the GO Fund. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F11 · ownership.nature: The GO Fund is the record holder of the Swaps. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to the GO Fund. The Reporting Person shares voting and dispositive power over the Swaps held by the GO Fund and may be deemed to beneficially own such Swaps. Read SEC document
May 21, 2026 Filed May 21, 2026 21:43 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	370,462	$93.45	$34,619,007.07	Disclosure SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 7 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 4,824,799 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F9 · price: This price reflects the weighted average price for open-market sales of Shares on May 21, 2026 within a $1.00 range. The actual prices for these transactions range from $93.125 to $93.83, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 20, 2026 Filed May 21, 2026 21:43 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	800	$96.28	$77,025.52	Disclosure SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 6 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 5,195,261 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F8 · price: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $96.25 to $96.34, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 20, 2026 Filed May 21, 2026 21:43 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	66,881	$95.67	$6,398,204.31	Disclosure SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 5 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 5,196,061 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F7 · price: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $95.25 to $96.21, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 20, 2026 Filed May 21, 2026 21:43 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	152,691	$94.81	$14,476,038.22	Disclosure SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 4 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 5,262,942 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F6 · price: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $94.25 to $95.245, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 20, 2026 Filed May 21, 2026 21:43 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	797,628	$93.48	$74,559,553.50	Disclosure SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 3 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 5,415,633 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F5 · price: This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $93.25 to $94.19, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 19, 2026 Filed May 21, 2026 21:43 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	151	$95.18	$14,372.18	Disclosure SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 2 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 6,213,261 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 19, 2026 Filed May 21, 2026 21:43 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	1,983,387	$94.45	$187,326,935.38	Disclosure SEC source: 0000905148-26-002617 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 6,213,412 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F2 · price: This price reflects the weighted average price for open-market sales of Shares on May 19, 2026 within a $1.00 range. The actual prices for these transactions range from $94.18 to $95.175, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 14, 2026 Filed May 15, 2026 21:04 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantDeferred Stock Units · Derivative	1,930.0051	$97.15 Strike: $0.00	$187,500.00	Disclosure SEC source: 0000064803-26-000058 · form4.xml · derivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,147.6418 Underlying: Common Stock · 1,930.0051 shares Expires not disclosed F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. Read SEC document
December 11, 2025 Filed Dec 15, 2025 23:20 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	21,370	$3.02	$64,471.15	Disclosure SEC source: 0000905148-25-004355 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 14,335,055 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F2 · price: This price reflects the weighted average price for open-market purchases of Shares on December 11, 2025 within a $1.00 range. The actual prices for these transactions range from $3.015 to $3.02, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F3 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
December 05, 2025 Filed Dec 5, 2025 22:40 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	200,000	$3.06	$611,300.00	Disclosure SEC source: 0000905148-25-004254 · form4.xml · nonDerivative · entry 3 ROBBINS LARRY · CIK 0001228603 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 14,313,685 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F4 · price: This price reflects the weighted average price for open-market purchases of Shares on December 5, 2025 within a $1.00 range. The actual prices for these transactions range from $3.0123 to $3.06, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F5 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F7 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
December 04, 2025 Filed Dec 5, 2025 22:40 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	536,893	$2.99	$1,607,833.47	Disclosure SEC source: 0000905148-25-004254 · form4.xml · nonDerivative · entry 2 ROBBINS LARRY · CIK 0001228603 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 14,113,685 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F3 · price: This price reflects the weighted average price for open-market purchases of Shares on December 4, 2025 within a $1.00 range. The actual prices for these transactions range from $2.865 to $3.06, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F5 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F7 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
December 03, 2025 Filed Dec 5, 2025 22:40 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	821,648	$2.96	$2,433,639.21	Disclosure SEC source: 0000905148-25-004254 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 13,576,792 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F2 · price: This price reflects the weighted average price for open-market purchases of Shares on December 3, 2025 within a $1.00 range. The actual prices for these transactions range from $2.83 to $2.97, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F5 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F7 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
November 21, 2025 Filed Nov 21, 2025 22:35 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	800,000	$2.58	$2,064,160.00	Disclosure SEC source: 0000905148-25-004157 · form4.xml · nonDerivative · entry 3 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 12,755,144 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F4 · price: This price reflects the weighted average price for open-market purchases of Shares on November 21, 2025 within a $1.00 range. The actual prices for these transactions range from $2.355 to $2.65, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F5 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F7 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
November 20, 2025 Filed Nov 21, 2025 22:35 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	1,000,000	$2.37	$2,366,000.00	Disclosure SEC source: 0000905148-25-004157 · form4.xml · nonDerivative · entry 2 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 11,955,144 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F3 · price: This price reflects the weighted average price for open-market purchases of Shares on November 20, 2025 within a $1.00 range. The actual prices for these transactions range from $2.305 to $2.43, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F5 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F7 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
November 20, 2025 Filed Nov 21, 2025 22:45 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantDeferred Stock Units · Derivative	2,202.788	$76.04 Strike: $0.00	$167,500.00	Disclosure SEC source: 0000064803-25-000065 · form4.xml · derivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,080.2915 Underlying: Common Stock · 2,202.788 shares Expires not disclosed F1 · shares: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. Read SEC document
November 19, 2025 Filed Nov 21, 2025 22:35 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	1,000,000	$2.35	$2,353,900.00	Disclosure SEC source: 0000905148-25-004157 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 10,955,144 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F2 · price: This price reflects the weighted average price for open-market purchases of Shares on November 19, 2025 within a $1.00 range. The actual prices for these transactions range from $2.0137 to $2.50, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F5 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F7 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:33 UTC	Butterfly Network, Inc. BFLY · Entity 4467	GrantClass A Common Stock	80,434	$0.00	$0.00	Disclosure SEC source: 0001062993-25-011828 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,505 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2026 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date. Read SEC document
May 15, 2025 Filed May 19, 2025 21:48 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantDeferred Stock Units · Derivative	2,769.9686	$60.47 Strike: $0.00	$167,500.00	Disclosure SEC source: 0001127602-25-014958 · form4.xml · derivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,766.7068 Underlying: Common Stock · 2,769.9686 shares Expires not disclosed F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. Read SEC document
May 06, 2025 Filed May 6, 2025 20:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	150,000	$66.67	$10,000,710.00	Disclosure SEC source: 0000905148-25-001466 · form4.xml · nonDerivative · entry 6 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 8,196,799 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F9 · price: This price reflects the weighted average price for open-market sales of Shares on May 6, 2025 within a $1.00 range. The actual prices for these transactions range from $66.235 to $67.05, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 05, 2025 Filed May 6, 2025 20:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	96,999	$67.99	$6,595,272.41	Disclosure SEC source: 0000905148-25-001466 · form4.xml · nonDerivative · entry 5 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 8,346,799 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F8 · price: This price reflects the weighted average price for open-market sales of Shares on May 5, 2025 within a $1.00 range. The actual prices for these transactions range from $67.925 to $68.26, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 05, 2025 Filed May 6, 2025 20:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	1,226,933	$67.37	$82,654,672.72	Disclosure SEC source: 0000905148-25-001466 · form4.xml · nonDerivative · entry 4 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 8,443,798 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F7 · price: This price reflects the weighted average price for open-market sales of Shares on May 5, 2025 within a $1.00 range. The actual prices for these transactions range from $66.925 to $67.92, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 02, 2025 Filed May 6, 2025 20:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	373,776	$69.66	$26,035,591.55	Disclosure SEC source: 0000905148-25-001466 · form4.xml · nonDerivative · entry 3 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 9,670,731 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F6 · price: This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $69.0817 to $70.035, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 02, 2025 Filed May 6, 2025 20:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	222,556	$68.38	$15,218,980.18	Disclosure SEC source: 0000905148-25-001466 · form4.xml · nonDerivative · entry 2 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 10,044,507 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F5 · price: This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $68.08 to $69.0764, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
May 02, 2025 Filed May 6, 2025 20:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	1,679,736	$67.39	$113,190,186.18	Disclosure SEC source: 0000905148-25-001466 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Glenview Investment Funds Disclosed balance after: 10,267,063 F1 · security: These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F2 · price: This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $67.08 to $68.07, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. F4 · ownership.nature: The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. Read SEC document
November 21, 2024 Filed Nov 25, 2024 23:10 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantDeferred Stock Units · Derivative	2,933.4501	$57.10 Strike: $0.00	$167,500.00	Disclosure SEC source: 0001127602-24-028011 · form4.xml · derivative · entry 3 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,933.4501 Underlying: Common Stock · 2,933.4501 shares Expires not disclosed F6 · shares: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the 2017 Incentive Compensation Plan. F7 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. F7 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. Read SEC document
August 30, 2024 Filed Sep 4, 2024 20:34 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	244,774	$1.07	$262,250.86	Disclosure SEC source: 0000905148-24-002501 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,955,144 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F2 · price: This price reflects the weighted average price for open-market purchases of Shares on August 30, 2024 within a $1.00 range. The actual prices for these transactions range from $1.035 to $1.09, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F3 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
August 29, 2024 Filed Aug 30, 2024 20:18 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	429,919	$1.07	$461,990.96	Disclosure SEC source: 0000905148-24-002423 · form4.xml · nonDerivative · entry 3 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,710,370 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F3 · price: This price reflects the weighted average price for open-market purchases of Shares on August 29, 2024 within a $1.00 range. The actual prices for these transactions range from $1.01 to $1.10, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F4 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F6 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
August 28, 2024 Filed Aug 30, 2024 20:18 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	294,673	$0.99	$292,816.56	Disclosure SEC source: 0000905148-24-002423 · form4.xml · nonDerivative · entry 2 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,280,451 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F2 · price: This price reflects the weighted average price for open-market purchases of Shares on August 28, 2024 within a $1.00 range. The actual prices for these transactions range from $0.952 to $1.00, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F4 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F6 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
August 28, 2024 Filed Aug 30, 2024 20:18 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	952,277	$0.98	$928,565.30	Disclosure SEC source: 0000905148-24-002423 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 8,985,778 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). F4 · ownership.nature: The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. F6 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:24 UTC	Butterfly Network, Inc. BFLY · Entity 4467	GrantClass A Common Stock	157,894	$0.00	$0.00	Disclosure SEC source: 0001104659-24-070860 · tm2417034-4_4seq1.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,071 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2025 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date. Read SEC document
June 20, 2023 Filed Jun 22, 2023 20:31 UTC	Butterfly Network, Inc. BFLY · Entity 4467	GrantClass A Common Stock	65,789	$0.00	$0.00	Disclosure SEC source: 0001104659-23-073789 · tm2319416-5_4seq1.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,177 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2024 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date. Read SEC document
June 20, 2023 Filed Jun 27, 2023 23:00 UTC Amendment	Butterfly Network, Inc. BFLY · Entity 4467	GrantClass A Common Stock	65,789	$0.00	$0.00	Disclosure SEC source: 0001104659-23-075382 · tm2319790-2_4aseq1.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,177 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2024 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date. Read SEC document
June 17, 2022 Filed Jun 22, 2022 20:08 UTC	Butterfly Network, Inc. BFLY · Entity 4467	GrantClass A Common Stock	48,231	$0.00	$0.00	Disclosure SEC source: 0001104659-22-073490 · tm2219003-2_4seq1.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,388 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date. Read SEC document
March 15, 2022 Filed Mar 15, 2022 21:01 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	500,000	$4.50	$2,251,400.00	Disclosure SEC source: 0001567619-22-006997 · doc1.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,464,751 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. F2 · price: This price reflects the weighted average price for open-market purchases of Shares on March 15, 2022 within a $1.00 range. The actual prices for these transactions range from $4.405 to $4.65, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F3 · ownership.nature: Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the shares held by the Glenview Investment Funds and may be deemed to beneficially own such shares. F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
March 11, 2022 Filed Mar 11, 2022 22:00 UTC	Butterfly Network, Inc. BFLY · Entity 4467	OtherWarrants to purchase Class A Common Stock · Derivative	2,107,400	$0.00 Strike: $11.50	$0.00	Disclosure SEC source: 0001140361-22-009169 · form4.xml · derivative · entry 4 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,745,933 Underlying: Class A Common Stock · 2,107,400 shares Expires not disclosed F6 · kind: Longview distributed in kind these Warrants (as defined in footnote 7) to certain of its members on a pro rata basis based on their ownership interest in Longview, for no consideration. F7 · derivative.exercise_date: Each warrant entitles the holder, upon exercise, to purchase one Share at a price of $11.50 per Share (the "Warrants"). These Warrants became exercisable beginning May 26, 2021 and expire on February 12, 2026. F7 · derivative.expiration_date: Each warrant entitles the holder, upon exercise, to purchase one Share at a price of $11.50 per Share (the "Warrants"). These Warrants became exercisable beginning May 26, 2021 and expire on February 12, 2026. F2 · ownership.nature: Longview, or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. F4 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
March 11, 2022 Filed Mar 11, 2022 22:00 UTC	Butterfly Network, Inc. BFLY · Entity 4467	OtherClass A Common Stock	3,159,563	$0.00	$0.00	Disclosure SEC source: 0001140361-22-009169 · form4.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,115,437 F1 · kind: Longview Investors LLC ("Longview") distributed in kind these shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") to certain of its members on a pro rata basis based on their ownership interest in Longview, for no consideration. F2 · ownership.nature: Longview, or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. F4 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
July 01, 2021 Filed Jul 2, 2021 21:31 UTC	Butterfly Network, Inc. BFLY · Entity 4467	GrantStock Option (Right to Buy) · Derivative	21,645	$0.00 Strike: $14.25	$0.00	Disclosure SEC source: 0001562180-21-004732 · primarydocument.xml · derivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,645 Underlying: Common Stock · 21,645 shares Expires 2031-06-30 F1 · shares: These options were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. F2 · derivative.exercise_date: The option vests in full on the date of the Butterfly Network, Inc. 2022 Annual Stockholders meeting, subject to the Reporting Person's continued services on the Board of Directors on such date. Read SEC document
May 27, 2021 Filed May 28, 2021 20:24 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	39,905	$11.10	$442,797.85	Disclosure SEC source: 0001567619-21-011362 · doc1.xml · nonDerivative · entry 2 ROBBINS LARRY · CIK 0001228603 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,964,751 F3 · shares: These shares were purchased by Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P. and Glenview Offshore Opportunity Master Fund, Ltd. F4 · price: This price reflects the weighted average price for open-market purchases of Shares on May 27, 2021 within a $1.00 range. The actual prices for these transactions range from $11.06 to $11.10, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F5 · ownership.nature: Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the shares held by the Glenview Investment Funds and may be deemed to beneficially own such shares. F7 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any Shares owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
May 26, 2021 Filed May 28, 2021 20:24 UTC	Butterfly Network, Inc. BFLY · Entity 4467	PurchaseClass A Common Stock	150,000	$11.09	$1,663,995.00	Disclosure SEC source: 0001567619-21-011362 · doc1.xml · nonDerivative · entry 1 ROBBINS LARRY · CIK 0001228603 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,924,846 F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Healthcare Master Fund, L.P. F2 · price: This price reflects the weighted average price for open-market purchases of Shares on May 26, 2021 within a $1.00 range. The actual prices for these transactions range from $11.03 to $11.13, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. F5 · ownership.nature: Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the shares held by the Glenview Investment Funds and may be deemed to beneficially own such shares. F7 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any Shares owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Read SEC document
April 22, 2021 Filed Apr 22, 2021 20:27 UTC	TENET HEALTHCARE CORP THC · Entity 2563	SaleCommon Stock, $0.05 par value	26,197	$56.25	$1,473,507.90	Disclosure SEC source: 0001140361-21-013902 · form4.xml · nonDerivative · entry 7 GLENVIEW CAPITAL MANAGEMENT, LLC · CIK 0001138995 · 10% owner ROBBINS LARRY · CIK 0001228603 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F7 · price: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $56.22 to $56.42, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F9 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document
April 22, 2021 Filed Apr 22, 2021 20:27 UTC	TENET HEALTHCARE CORP THC · Entity 2563	SaleCommon Stock, $0.05 par value	26,197	$54.95	$1,439,653.52	Disclosure SEC source: 0001140361-21-013902 · form4.xml · nonDerivative · entry 6 GLENVIEW CAPITAL MANAGEMENT, LLC · CIK 0001138995 · 10% owner ROBBINS LARRY · CIK 0001228603 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,197 F6 · price: This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $54.87 to $54.99, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. F9 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.